In situ hybridization and antibody staining was carried out as described previously [65 (link)–67 (link)]. In situ TUNEL assay was performed by using Promega terminal deoxynucleotidyl transferase (M828A) according to the manufacturer’s protocol. Following primary and secondary antibodies were used in this study: anti-Islet1/2 (Developmental Studies Hybridoma Bank 39.4D5, 1:100 for whole-mount, 1:250 for cryo-sections), anti-BrdU (Beckton-Dickinson, 1:250) and Alexa 546 goat anti-mouse IgG (Invitrogen A-11003, 1:50 for whole-mount, 1:250 for cryo-sections). Cryo-sectioning and BrdU labeling were carried out as described previously [5 (link)]. Whole-mount stained embryos were sectioned except for Figs. 1, 7 and S4 where anti-Islet1/2 staining was performed on sections using standard whole mount protocols.
Free full text: Click here